Global BioAccess Fund

Sobre

Global BioAccess Fund backs therapeutics and medical-device companies addressing serious unmet needs in oncology, immunology, cardiovascular disease, CNS, and rare disease. It most often invests from Series A to C, can lead or co-lead, and may invest up to $10 million over a company's lifespan.

Sectores

• Ciencias de la vida
• Salud / Salud digital

Inversiones destacadas

• Odyssey Therapeutics
• Epsilogen
• Vittoria Biotherapeutics
• Cartography Biosciences
• Acesion Pharma
• Shiratronics
• Ensho Therapeutics
• Nuvig Therapeutics
• Alveus Therapeutics

Inversores

• Bruce RobertsManaging Partner→
• Dave PraharajSenior Associate→
• Kevin CyrResearch Associate→
• Lisa WisniewskiManaging Director→
• Sonia GulatiPrincipal→
• Ted MoonManaging Partner→

Cómo contactarlos

info@globalbioaccess.com